GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 188 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $267,020 | +113.1% | 3,921 | 0.0% | 0.01% | +160.0% |
Q2 2022 | $125,276 | -7.8% | 3,921 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $135,823 | -72.1% | 3,921 | -76.4% | 0.01% | -28.6% |
Q4 2021 | $486,409 | +14.9% | 16,618 | 0.0% | 0.01% | +16.7% |
Q3 2021 | $423,427 | -27.2% | 16,618 | 0.0% | 0.01% | -25.0% |
Q2 2021 | $581,962 | +231.1% | 16,618 | +285.3% | 0.01% | +166.7% |
Q1 2021 | $175,755 | -10.0% | 4,313 | -4.3% | 0.00% | 0.0% |
Q4 2020 | $195,241 | -21.9% | 4,508 | -0.5% | 0.00% | -25.0% |
Q3 2020 | $249,894 | -14.9% | 4,532 | -2.5% | 0.00% | -20.0% |
Q2 2020 | $293,491 | -67.4% | 4,649 | -73.6% | 0.01% | -73.7% |
Q1 2020 | $901,177 | -34.9% | 17,639 | +1.2% | 0.02% | -17.4% |
Q4 2019 | $1,385,034 | +58.9% | 17,424 | -3.0% | 0.02% | +53.3% |
Q3 2019 | $871,565 | -3.4% | 17,963 | +4.7% | 0.02% | 0.0% |
Q2 2019 | $902,405 | +1.0% | 17,156 | +1.7% | 0.02% | -6.2% |
Q1 2019 | $893,088 | +33.4% | 16,873 | +3.4% | 0.02% | +23.1% |
Q4 2018 | $669,567 | +8.0% | 16,311 | 0.0% | 0.01% | +18.2% |
Q3 2018 | $619,818 | -99.9% | 16,311 | 0.0% | 0.01% | -8.3% |
Q2 2018 | $737,257,000 | +24.3% | 16,311 | +32.8% | 0.01% | +50.0% |
Q1 2018 | $593,172,000 | +124778.3% | 12,281 | +1.8% | 0.01% | +33.3% |
Q4 2017 | $475,000 | -40.0% | 12,066 | -52.7% | 0.01% | +20.0% |
Q3 2017 | $792,000 | +13.6% | 25,492 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $697,000 | +64.0% | 25,492 | +121.0% | 0.01% | +66.7% |
Q1 2017 | $425,000 | +154.5% | 11,535 | 0.0% | 0.00% | +200.0% |
Q4 2016 | $167,000 | -37.2% | 11,535 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $266,000 | +39.3% | 11,535 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $191,000 | -17.3% | 11,535 | +61.1% | 0.00% | -50.0% |
Q4 2015 | $231,000 | – | 7,158 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
Grace Capital | 244,914 | $12,882,000 | 6.14% |
Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |